Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8317380 | Clinical Biochemistry | 2014 | 4 Pages |
Abstract
Dialysate calcium concentration is known to have both immediate and longer-term impact on parathyroid hormone levels in hemodialysis patients. Little is known about the acute impact of dialysate calcium on bone metabolism. In this cross-sectional study of prevalent hemodialysis patients, we found no evidence of immediate short-term dialysate calcium-induced changes of fibroblast growth factor 23 or anabolic and catabolic markers of bone turnover during hemodialysis. However, differences in CTX-I and to a lesser extent other parameters between groups of higher and lower dialysate calcium suggest a longer-term effect that remains to be validated.
Keywords
SCATRAP5bCTX-IFGF23C-telopeptideBALPP1NPHDFiPTHOsteocalcinbone specific alkaline phosphataseBeta2-microglobulinBUNrenal dialysisDialysis solutionsSerum calciumfibroblast growth factor 23serum phosphateInorganic phosphatesRenal insufficiency, chronicblood urea nitrogenHemodiafiltrationHemodialysisparathyroid hormoneIntact parathyroid hormone
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Bernhard O. Bielesz, Manfred Hecking, Max Plischke, Daniel Cejka, Heidi Kieweg, Martin Haas, Rodrig Marculescu, Walter H. Hörl, Christian Bieglmayer, Gere Sunder-Plassmann,